Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CSA Medical, Inc.
With
Reset Medical, Inc.
The proposed registry is a prospective, multi-center study of patients that are currently undergoing CryoSpray Ablation™. A maximum of 50 investigational sites will participate in this study.
The study population consists of patients who are being treated with the CryoSpray Ablation™ System for thoracic diseases. Enrolled subjects must have a signed consent form for data collection.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who are being treated with the CryoSpray Ablation™ System for lung and for thoracic diseases.
You may not be if
Subjects with thoracic or airway obstructions and diseases who were not treated with the CryoSpray Ablation™ System.
Subjects under the age of 18 years.
Subjects unable to provide consent.
Clareo Health | CryoSpray Ablation(tm)Thoracic Patient Registry
